Literature DB >> 31595421

Long non-coding RNA LINC00243 promotes proliferation and glycolysis in non-small cell lung cancer cells by positively regulating PDK4 through sponging miR-507.

Xuegang Feng1, Shengsheng Yang2.   

Abstract

Non-small cell lung cancer (NSCLC) is the main subtype of lung cancer. The overall survival of NSCLC patients is relatively low even after various treatments. Accumulating evidence demonstrated that long non-coding RNA (LncRNA) plays crucial roles in different biological process. However, the role of a novel LncRNA, LINC00243, in NSCLC remains unclear. We aimed to explore the biological role of LINC00243 in NSCLC. The mRNA and protein levels were determined by real-time PCR and western blot, respectively. Cell viability in vitro was detected by Cell Counting Kit-8 (CCK-8) assay and colony-formation assay. Reporter assay was used to detect the interactions between molecules, and the interaction was assessed by RNA pull-down assay. LINC00243 expression increased in human NSCLC tissues and associated with poor prognosis of NSCLC patients. LINC00243 knockdown inhibited proliferation and glycolysis of NSCLC cells. Mechanically, LINC00243 acted as a molecular sponge for miR-507, and miR-507 reversed the effect of LINC00243 on promoting proliferation and glycolysis of NSCLC cells. Moreover, LINC00243 modulated expression of endogenous miR-507-targeted PDK4. LINC00243 promotes proliferation and glycolysis in NSCLC cells by positively regulating PDK4 through sponging miR-507. LINC00243 could be the potential target for NSCLC treatment clinically.

Entities:  

Keywords:  Glycolysis; LINC00243; NSCLC; PDK4; Proliferation; miR-507

Mesh:

Substances:

Year:  2019        PMID: 31595421     DOI: 10.1007/s11010-019-03635-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

Review 1.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation.

Authors:  Sophia Y Lunt; Matthew G Vander Heiden
Journal:  Annu Rev Cell Dev Biol       Date:  2011       Impact factor: 13.827

Review 2.  Lung cancer.

Authors:  Roy S Herbst; John V Heymach; Scott M Lippman
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

3.  The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis.

Authors:  G Li; M Li; J Hu; R Lei; H Xiong; H Ji; H Yin; Q Wei; G Hu
Journal:  Oncogene       Date:  2016-09-19       Impact factor: 9.867

4.  Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study.

Authors:  Scott Antonia; Sarah B Goldberg; Ani Balmanoukian; Jamie E Chaft; Rachel E Sanborn; Ashok Gupta; Rajesh Narwal; Keith Steele; Yu Gu; Joyson J Karakunnel; Naiyer A Rizvi
Journal:  Lancet Oncol       Date:  2016-02-06       Impact factor: 41.316

5.  Overall survival in non-small cell lung cancer-what is clinically meaningful?

Authors:  Klaus Fenchel; Ludger Sellmann; Wolfram C M Dempke
Journal:  Transl Lung Cancer Res       Date:  2016-02

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 7.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

8.  FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy.

Authors:  Dickran Kazandjian; Daniel L Suzman; Gideon Blumenthal; Sirisha Mushti; Kun He; Meredith Libeg; Patricia Keegan; Richard Pazdur
Journal:  Oncologist       Date:  2016-03-16

Review 9.  Targeting Lung Cancer Stem Cells: Research and Clinical Impacts.

Authors:  Norashikin Zakaria; Nazilah Abdul Satar; Noor Hanis Abu Halim; Siti Hawa Ngalim; Narazah Mohd Yusoff; Juntang Lin; Badrul Hisham Yahaya
Journal:  Front Oncol       Date:  2017-05-05       Impact factor: 6.244

10.  Overexpression of PDK4 is associated with cell proliferation, drug resistance and poor prognosis in ovarian cancer.

Authors:  Jinghao Wang; Yu Qian; Meiyan Gao
Journal:  Cancer Manag Res       Date:  2018-12-24       Impact factor: 3.989

View more
  8 in total

Review 1.  Functions of lncRNA DUXAP8 in non-small cell lung cancer.

Authors:  Cui Wu; Wu Song; Zhongnan Wang; Bingmei Wang
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.316

Review 2.  Long Noncoding RNAs and Circular RNAs in the Metabolic Reprogramming of Lung Cancer: Functions, Mechanisms, and Clinical Potential.

Authors:  Yuhao Zhou; Yuan Zhan; Weiling Jiang; Huiguo Liu; Shuang Wei
Journal:  Oxid Med Cell Longev       Date:  2022-06-15       Impact factor: 7.310

Review 3.  ChrXq27.3 miRNA cluster functions in cancer development.

Authors:  Kosuke Yoshida; Akira Yokoi; Yusuke Yamamoto; Hiroaki Kajiyama
Journal:  J Exp Clin Cancer Res       Date:  2021-03-25

4.  Long noncoding RNA NR2F1-AS1 stimulates the tumorigenic behavior of non-small cell lung cancer cells by sponging miR-363-3p to increase SOX4.

Authors:  Luming Jin; Chaoyang Chen; Lipeng Huang; Qingyu Sun; Liang Bu
Journal:  Open Med (Wars)       Date:  2021-12-16

5.  Screening and verification of prognostic lncRNA markers related to immune infiltration in the metastasis of osteosarcoma.

Authors:  Chuan He; Xiaolong Wang; Linying Ni; Chunyu Song; Wei Mai
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

6.  MiR-5683 suppresses glycolysis and proliferation through targeting pyruvate dehydrogenase kinase 4 in gastric cancer.

Authors:  Yongchang Miao; Qing Li; Guangli Sun; Lu Wang; Diancai Zhang; Hao Xu; Zekuan Xu
Journal:  Cancer Med       Date:  2020-08-11       Impact factor: 4.452

7.  circ_0005962 functions as an oncogene to aggravate NSCLC progression.

Authors:  Zhihong Zhang; Zhenxiu Shan; Rubin Chen; Xiaorong Peng; Bin Xu; Liang Xiao; Guofei Zhang
Journal:  Open Med (Wars)       Date:  2021-07-02

8.  A unified framework identifies new links between plasma lipids and diseases from electronic medical records across large-scale cohorts.

Authors:  Yogasudha Veturi; Anastasia Lucas; Yuki Bradford; Daniel Hui; Scott Dudek; Elizabeth Theusch; Anurag Verma; Jason E Miller; Iftikhar Kullo; Hakon Hakonarson; Patrick Sleiman; Daniel Schaid; Charles M Stein; Digna R Velez Edwards; QiPing Feng; Wei-Qi Wei; Marisa W Medina; Ronald M Krauss; Thomas J Hoffmann; Neil Risch; Benjamin F Voight; Daniel J Rader; Marylyn D Ritchie
Journal:  Nat Genet       Date:  2021-06-17       Impact factor: 38.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.